(TSX:TSU), TORONTO, Aug. 07, 2025 (GLOBE NEWSWIRE) — Trisura Group Ltd. (“Trisura” or “Trisura Group”) (TSX: TSU), a leading specialty insurance provider, today announced financial results for the second quarter of 2025. David Clare, President and CEO of Trisura, stated, “In Q2, we achieved a strong Operating ROE of 17.8% with Operating net income of […]
(NASDAQ:SBET), MINNEAPOLIS, MN, Aug. 07, 2025 (GLOBE NEWSWIRE) — SharpLink Gaming, Inc. (Nasdaq: SBET) (“SharpLink” or the “Company”), one of the world's largest corporate holders of Ether (“ETH”) and prominent industry advocate of Ethereum adoption, today announced that the Company will host a conference call and webcast on Friday, August 15, 2025 beginning at 8:30
(NASDAQ:LFCR), — Recorded $128.9 Million in Fiscal 2025 Revenue, Meeting Full-Year Guidance; Maintains Commitment to Mid-Term Outlook — — Nine New Programs Signed with New Customers During Fiscal 2025, Reflecting Growth into Modalities Beyond the Company's Traditional Area of Strength in Ophthalmic Therapeutics — — Improved Efficiency and Productivity Across the Organization — Conference Call
London, Aug. 07, 2025 (GLOBE NEWSWIRE) — Pixalate, the leading ad fraud protection, privacy, and compliance analytics platform, today released the United Kingdom July 2025 Top Mobile Gaming Apps Rankings for Programmatic Advertising Traffic Quality on the Apple App Store and the Google Play Store. The report ranks mobile apps in the 'Video Gaming' IAB
(NasdaqGM:RLAY), Presented updated data at ASCO showing consistency with prior data, including 10.3-month median PFS and 39% ORR in patients with PI3Kα-mutated, HR+/HER2- metastatic breast cancer Initiated Phase 3 ReDiscover-2 trial in Q2 Approximately $657 million in cash, cash equivalents and investments at end of Q2 2025 CAMBRIDGE, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) —
(NASDAQ:APYX), CLEARWATER, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) — Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical”; the “Company”) today announced that on August 4, 2025, Apyx granted a nonstatuatory stock option to purchase 100,000 shares of common stock to John Featherstone, Apyx's Vice President, North American Sales as a material inducement to such employee's employment and
Net Revenues of $1.254 billion, Up 6.6% (6.2% constant currency)1 Data-Tech-AI Net Revenues of $599 million, Up 9.7% (9.5% constant currency)1 Digital Operations Net Revenues of $655 million, Up 4.0% (3.4% constant currency)1 Advanced Technology Solutions Net Revenues2 of $293 million, Up 17.3% Core Business Services Net Revenues2 of $962 million, Up 3.8% Diluted EPS
(NASDAQ:BIRD), Delivers Second Quarter Results in Line with and Above Guidance Ranges Revises Full Year 2025 Revenue Outlook and Reiterates Adjusted EBITDA Guidance Product, Marketing and Customer Experience Initiatives Expected to Fuel Revenue Growth in Q4 2025 SAN FRANCISCO, Aug. 07, 2025 (GLOBE NEWSWIRE) — Allbirds, Inc. (NASDAQ: BIRD), a global lifestyle brand that innovates
(NASDAQ:INMB), BOCA RATON, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) — INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient's innate immune system to fight disease, today announces its financial results for the quarter ended June 30, 2025 and provides a business update. Q2 2025 and
(NasdaqGM:TRUP), SEATTLE, Aug. 07, 2025 (GLOBE NEWSWIRE) — Trupanion, Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs, today announced financial results for the second quarter ended June 30, 2025. “The second quarter was one of the strongest financial quarters in our history, marked by consistent top-line growth, robust margin expansion